Association between biomass cooking fuels and prevalence of tuberculosis among households: a cross-sectional study from 2019 – 2021 in India.

Publication date: Dec 31, 2024

Indoor air pollution (IAP) is the major contributor (26%) to TB, in addition to other socioeconomic and environmental factors. It occurs in most developing countries like India, where people rely on the combustion of biomass-based solid fuels (low combustion efficiency and high pollution emissions) due to the prevailing socio-economic conditions. However, this cause-and-effect relationship between TB and IAP has not been studied much. The current study tries to bridge the gap and analyze the cause-effect relationship to come up with concrete remedies for its minimization and help secure the holy grail of TB-free India. The current analysis was done on the fifth round of the National Family Health Survey (NFHS-5), 2019-21 database in India. A total of six sets of questionnaires were used to evaluate the prevalence of TB among households. The questionnaire “Does any member of your household suffer from tuberculosis?” was utilized, which helped identify the TB-affected individuals among household members. Binary logistic regression was performed to analyze the household environment and TB association. The use of biomass-based solid fuel for cooking and other household environmental factors are measured by adjusted odds ratio (aOR: 1. 171; 95% confidence interval (CI): 1. 107-1. 238; P-value 

Open Access PDF

Concepts Keywords
Cooking Adolescent
Environmental Adult
Socioeconomic Air Pollution, Indoor
Tuberculosis Biomass
Biomass
Child
Cooking
Cooking-fuel
Cross-Sectional Studies
Environment
Family Characteristics
Female
Health Surveys
Household
Humans
India
Male
Middle Aged
Prevalence
Tuberculosis
Tuberculosis
Young Adult

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Medical air
disease MESH Family Health
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
drug DRUGBANK Carbon monoxide
disease MESH respiratory infections
disease MESH COPD
disease MESH lung cancer
disease MESH asthma
pathway KEGG Asthma
disease MESH pulmonary tuberculosis
disease MESH infection
drug DRUGBANK Water
disease MESH death
disease MESH heart diseases
disease MESH COVID 19
disease IDO country
disease MESH pneumonia
disease MESH respiratory diseases
drug DRUGBANK Indoleacetic acid
disease MESH morbidity
disease MESH educational attainment
disease MESH marital status
disease IDO geographical region
drug DRUGBANK Carbon Black
drug DRUGBANK Activated charcoal
disease MESH non communicable diseases
disease MESH stroke
drug DRUGBANK Carbon dioxide
drug DRUGBANK Nitric Oxide
disease IDO host
drug DRUGBANK Nicotine
disease IDO production
disease MESH persistent infection
disease MESH defects
disease IDO blood
drug DRUGBANK Oxygen
drug DRUGBANK Formaldehyde
disease MESH oxidative stress
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH complications
drug DRUGBANK Aspartame
disease IDO quality
disease MESH angle closure glaucoma
disease MESH infectious diseases

Leave a Comment

Your email address will not be published. Required fields are marked *